Apex Trader Funding (ATF) - News
Dow Jumps 200 Points; Pfizer Earnings Top Views
U.S. stocks traded mostly higher this morning, with the Dow Jones index gaining around 200 points on Tuesday.
Following the market opening Tuesday, the Dow traded up 0.50% to 40,742.44 while the NASDAQ slipped 0.01% to 17,370.07. The S&P 500 also rose, gaining, 0.22% to 5,475.80.
Check This Out: Top 3 Financials Stocks Which Could Rescue Your Portfolio For July
Leading and Lagging SectorsFinancials shares jumped by 1.3% on Tuesday.
In trading on Tuesday, consumer staples shares fell by 1%.
Top Headline
Pfizer Inc. (NYSE:PFE) reported better-than-expected second-quarter financial results.
Pfizer reported second-quarter adjusted EPS of 60 cents, down 11% year over year, beating the consensus of 46 cents. The U.S. drugmaker reported sales of $13.28 billion, up 2% year-over-year (up 3% operationally), beating the consensus of $13.02 billion.
Pfizer updated its 2024 revenue forecast to $59.5 billion—$62.5 billion, compared to prior guidance of $58.5 billion—$61.5 billion and consensus of $60.7 billion. Pfizer expects 2024 adjusted EPS of $2.45-$2.65 compared to prior guidance of $2.15-$2.35 and consensus of $2.37.
Equities Trading UP
Imunon, Inc. (NASDAQ:IMNN) shares shot up 158% to $3.0500 after the company announced topline results from its Phase 2 OVATION 2 study with IMNN-001. The results showed an 11.1-month improvement in median overall survival compared ...